The US is at risk for dengue fever
The buzz surrounding the mosquito-borne illness
![Dengue fever test.](https://cdn.statically.io/img/cdn.mos.cms.futurecdn.net/rqBi5Q2zEYVUrj8vn8oEwZ-415-80.jpg)
As the weather warms, mosquitos are expanding their range. With that, mosquito-borne illnesses are also becoming more commonplace. The newest risk to the U.S. is dengue fever, the instances of which have skyrocketed in 2024. The disease has the potential to be deadly if left untreated and is likely going to become more routine as climate change worsens.
What is dengue fever?
Dengue fever is a mosquito-borne viral illness mostly present in tropical climates. However, the U.S. has begun to see a spike in cases amid warming temperatures. According to the Centers for Disease Control and Prevention (CDC), the U.S. saw a "higher-than-expected" 2,241 new cases, including 1,498 in Puerto Rico between January 1 and July 24, 2024. The highest number of cases in the continental U.S. was seen in Florida, New York and Massachusetts. The problem is not just limited to the U.S. "As of June 24, 2024, more than 9.7 million dengue cases have been reported in the Americas, twice as many as in all of 2023," the CDC said.
Dengue fever is spread through the Aedes species of mosquito. Symptoms of the disease can "present as fever accompanied by non-specific signs and symptoms such as nausea, vomiting, rash, muscle aches, joint pain, bone pain, pain behind the eyes, headache or low white blood cell counts," said the CDC. However, approximately 5% of cases can progress to severe dengue which can cause "plasma, the protein-rich fluid component of blood, to leak out of blood vessels," said The New York Times. "Some patients may go into shock, causing organ failure." The good news is that only one in four cases of dengue fever are symptomatic at all and even severe cases have a high rate of survival, if treated.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.statically.io/img/cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Is there a cure?
There are no antiviral medications that have been approved to treat dengue fever. Instead symptoms are managed with medication like acetaminophen and patients are advised to rest, stay hydrated and closely monitor conditions. Severe cases may require hospitalization. Some antivirals are currently in clinical trials.
Prevention is the best option. Experts recommend "staying in places with air conditioning when possible, using insect repellent and wearing long sleeves and pants to avoid mosquito bites," said NBC News. There is one approved vaccine for dengue fever, but it is only recommended for ages 6 to 16 years in locations with high transmission levels. Infants, the elderly and pregnant people are most at risk of contracting severe dengue.
What about the future?
Climate change does not spell optimism for mosquito-borne illnesses. "Dengue cases are likely to increase as global temperatures increase," said the CDC. "Higher temperatures can expand the range of the mosquitoes that spread dengue, as well as affect other factors that facilitate virus transmission like faster viral amplification in the mosquito, increased vector survival and changes in reproduction and biting rates." As of now, most dengue cases in the U.S. are the result of travel, but local outbreaks are starting to become more customary.
In addition, "the spread of the disease has been exacerbated by increasingly wet and warm summer months brought forward by El Niño," said Time. The U.S. is not at severe risk just yet, thanks to air conditioning and screened windows limiting exposure to mosquitos. Cases should stay low "as long as people keep living like they're living now," Thomas W. Scott, a dengue epidemiologist and professor emeritus at the University of California, Davis, said to the Times.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
The world's best floating hotels
The Week Recommends Leave dry land behind at these peaceful buoyant retreats
By Irenie Forshaw, The Week UK Published
-
'Harris hits trail — and Trump'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
For God and country: is religion in politics making a comeback?
Talking Point There are many MPs of faith in the new Labour government despite it being the most openly secular House of Commons in history
By Chas Newkey-Burden, The Week UK Published
-
Have we defeated malaria?
The Explainer Roll-out of low-cost vaccine means a world free from disease that claims 600,000 lives a year 'finally within sight'
By The Week UK Published
-
Neurocosmetics: the beauty trend blending mental health and skin care
The Explainer Could a moisturizer really shift your mood?
By Theara Coleman, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
What is sickle cell anaemia?
The Explainer The UK has approved the use of a new drug to treat a disease that predominantly affects people of colour
By Keumars Afifi-Sabet, The Week UK Published
-
A study found toxic heavy metals in most tampon brands. Are they safe to use?
The Explainer Over a dozen brands tested positive, including organic tampons
By Theara Coleman, The Week US Published
-
The great baby bust
The Explainer The fertility rate is falling sharply in the UK and across the world, a trend with major economic and societal consequences
By The Week UK Published
-
Why perimenopause is being called the second puberty
The Explainer Many women are uninformed about this little-discussed stage of life
By Anya Jaremko-Greenwold, The Week US Published
-
A 'transformative' gene therapy for haemophilia B
The Explainer Costly treatment that could be 'truly life-changing' for patients with rare blood disorder gets funding boost
By Julia O'Driscoll, The Week UK Published